Providing Alternative Measures for Addressing Adverse Drug-Drug Interactions
暂无分享,去创建一个
[1] José Neves,et al. Representation of Clinical Practice Guideline Components in OWL , 2013, PAAMS.
[2] David Riaño,et al. Rule-Based Combination of Comorbid Treatments for Chronic Diseases Applied to Hypertension, Diabetes Mellitus and Heart Failure , 2012, ProHealth/KR4HC.
[3] Lawrence D. Phillips,et al. Is quantitative benefit-risk modelling of drugs desirable or possible? , 2011, Drug discovery today. Technologies.
[4] José Neves,et al. Decision Support Provided by a Temporally Oriented Health Care Assistant , 2016, Journal of Medical Systems.
[5] Syed Sibte Raza Abidi,et al. Merging Disease-Specific Clinical Guidelines to Handle Comorbidities in a Clinical Decision Support Setting , 2013, AIME.
[6] José Neves,et al. CompGuide: Acquisition and Editing of Computer-Interpretable Guidelines , 2017, WorldCIST.
[7] Szymon Wilk,et al. Comprehensive mitigation framework for concurrent application of multiple clinical practice guidelines , 2017, J. Biomed. Informatics.
[8] P. Aschner,et al. New IDF clinical practice recommendations for managing type 2 diabetes in primary care. , 2017, Diabetes research and clinical practice.
[9] James G Dolan,et al. Patients’ Preferences and Priorities Regarding Colorectal Cancer Screening , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.
[10] A. Wu,et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. , 2005, JAMA.
[11] Wei Ma,et al. RxNorm: prescription for electronic drug information exchange , 2005, IT Professional.
[12] Frank van Harmelen,et al. Analyzing interactions on combining multiple clinical guidelines , 2017, Artif. Intell. Medicine.